Open AccessExternal beam radiation therapy (EBRT) for asymptomatic bone metastases in patients with solid tumors reduces the risk of skeletal-related events (SREs)
Author(s) -
Rebecca M. Shulman,
Joshua E. Meyer,
Tianyu Li,
Krisha Howell
Publication year - 2019
Publication title -
annals of palliative medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.546
H-Index - 19
eISSN - 2224-5839
pISSN - 2224-5820
DOI - 10.21037/apm.2018.10.04
Subject(s) - medicine , asymptomatic , breast cancer , prostate cancer , cancer , external beam radiotherapy , radiation therapy , bone metastasis , lung cancer , surgery , radiology , oncology
The potential benefit of administering external beam radiation therapy (EBRT) to patients with asymptomatic bone metastases has rarely been addressed in clinical investigations. The aim of this study was to determine if cancer patients who were treated with EBRT for asymptomatic bone metastases experienced later onset of pain and skeletal-related events (SREs) than those who were untreated.